Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated July 28, 2025, titled "Financial Results Q1 FY 2026".
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vijaya Diagnostic Centre posted Q1 FY26 consolidated revenue of Rs. 1,880.5 million, up 20.4% year-on-year from Rs. 1,562.2 million, with an 8.6% sequential rise over Q4 FY25. EBITDA grew 20.1% YoY to Rs. 735.3 million while margins held nearly flat at 39.1%, but profit after tax rose only 3.5% YoY to Rs. 383.4 million, likely weighed down by higher depreciation and finance costs from the new expansion hubs. Operationally, total test volumes climbed 16.7% to 3.94 million and patient footfall grew 14.4% to 1.10 million, while average realization per test inched up 3.1% to Rs. 477. Management noted that new hubs in Pune, Bengaluru, and West Bengal are now operational, the Nizamabad hub reached break-even within two quarters, and three more hubs are slated to open in Q2 FY26.
Strong top-line and EBITDA growth reinforce the business momentum, but the sharp gap between EBITDA and PAT growth may concern investors in the near term. Expansion progress and improving volumes support a positive medium-term outlook for shareholders.